Syneos Health, Inc. (SYNH) Prices Secondary Stock Offering

Syneos Health, Inc. (Nasdaq: SYNH) announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 10,851,676 shares of the Company’s common stock. Syneos Health is not selling any shares and will not receive any proceeds from the proposed sale of the shares by the Selling Stockholders in the Offering. The Offering is expected to close on June 7, 2021, subject to customary closing conditions.

In addition, Syneos Health entered into an agreement with the Selling Stockholders to repurchase an aggregate of 500,000 shares of common stock from such Selling Stockholders in a private transaction, concurrently with the closing of the Offering, at the price at which the shares of common stock are sold to the public in the Offering, less underwriting discounts and commissions. The closing of the share repurchase is contingent on, and expected to occur simultaneously with, the closing of the Offering, subject to the satisfaction of other customary conditions. The closing of the Offering is not contingent on the closing of the share repurchase.

BofA Securities is acting as the sole underwriter of the Offering.

You May Also Be Interested In

• Paramount Global (PARA) and Skydance are closer to a merger - CNBC
• Lixte Biotechnology (LIXT) Files $50M Mixed Shelf
• Pulse Biosciences (PLSE) Files for 6M Rights Offering